We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Intranasal Therapeutics Gets $39 Million to Develop Sprays for Military
Intranasal Therapeutics Gets $39 Million to Develop Sprays for Military
August 16, 2006
Intranasal Therapeutics has received more than $39 million in venture capital to finish developing two nasal sprays — one to treat wounded U.S. soldiers being evacuated from combat zones in the Middle East, and one to treat victims of nerve gas attacks.